Assignee
ESPERVITA THERAPEUTICS INC
US·8 granted patents·3 pending applications·25 citations·filing 2020–2025
Top patents by PatentIndex Score
11 records- 0197US11267778B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2021·Granted Mar 8, 2022·6 cites·2 claims
- 0297US11098002B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2020·Granted Aug 24, 2021·5 cites·1 claims
- 0397US11084773B1Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2021·Granted Aug 10, 2021·5 cites·1 claims
- 0496US12252467B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2024·Granted Mar 18, 2025·1 cites·16 claims
- 0595US12180151B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2023·Granted Dec 31, 2024·1 cites·4 claims
- 0695US11730712B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2022·Granted Aug 22, 2023·3 cites·21 claims
- 0789US11737995B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2022·Granted Aug 29, 2023·4 cites·20 claims
- 0882US2023007838A1Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0980US2025367149A1Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1077US2022402851A1Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1174US12396972B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2023·Granted Aug 26, 2025·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when ESPERVITA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →